REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,823 | +70.9% | 17,884 | +52.3% | 0.00% | 0.0% |
| Q1 2023 | $1,067 | +78.4% | 11,741 | -25.5% | 0.00% | 0.0% |
| Q4 2022 | $598 | -99.8% | 15,750 | +20.7% | 0.00% | – |
| Q3 2022 | $327,000 | -22.5% | 13,050 | -6.2% | 0.00% | – |
| Q2 2022 | $422,000 | -1.2% | 13,908 | +6.6% | 0.00% | – |
| Q1 2022 | $427,000 | -56.4% | 13,050 | -64.9% | 0.00% | -100.0% |
| Q4 2021 | $979,000 | +32533.3% | 37,150 | +37050.0% | 0.00% | – |
| Q3 2017 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |